Title Increased Liver and Spleen Accumulation of Tc-99m Methylene Diphosphonate Associated With Intravenous Injection of MRI Contrast Gadolinium-Diethylenetriaminepentaacetic Acid
Authors Zhang, Weifang
Zhang, Yanyan
Li, Xinxin
Jin, Zhonghui
Affiliation Peking Univ, Teaching Hosp 3, Dept Nucl Med, Beijing 100871, Peoples R China.
Peking Univ, Teaching Hosp 3, Dept Nucl Med, 49 N Hua Yuan Rd, Beijing 100871, Peoples R China.
Keywords Tc-99m-diphosphonate (MDP)
gadolinium-diethylenetriaminepentaaceticacid (Gd-DTPA)
bone scan
hepatic
splenic
MRI
MDP BONE-SCINTIGRAPHY
SPLENIC UPTAKE
HEPATIC-UPTAKE
MULTIPLE-MYELOMA
PATIENT
CALCIFICATION
ABNORMALITIES
AGENT
HMDP
Issue Date 2011
Publisher clinical nuclear medicine
Citation CLINICAL NUCLEAR MEDICINE.2011,36,(3),183-185.
Abstract Several conditions that can cause diffuse hepatic or splenic uptake of Tc-99m methylene diphosphonate (Tc-99m MDP) have been previously reported. Nevertheless, diffuse abnormal liver and spleen uptake of Tc-99m MDP associated with intravenous injection of magnetic resonance imaging contrast gadolinium-diethylenetriaminepentaacetic acid is not previously known. In our series, we reported diffuse increased Tc-99m MDP activity in the liver and spleen in bone scans in patients who received Tc-99m MDP injection shortly after contrast-enhanced magnetic resonance imaging.
URI http://hdl.handle.net/20.500.11897/344142
ISSN 0363-9762
DOI 10.1097/RLU.0b013e318208f12b
Indexed SCI(E)
PubMed
Appears in Collections: 第三医院

Files in This Work
There are no files associated with this item.

Web of Science®


6

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.